FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

ICH Presentation on Selective Safety Data Collection

The International Council for Harmonization posts a presentation outlining its finalized guidance entitled A Selective Approach to Safety Data Collect...

latest-news-card-1
Federal Register

Guide on ANDA In Vitro Permeation Studies

Federal Register notice: FDA makes available a draft guidance entitled In Vitro Permeation Test Studies for Topical Products Submitted in ANDAs.

latest-news-card-1
Federal Register

ANDA Physicochemical/Structural Characterization Guide

Federal Register notice: FDA makes available a draft guidance entitled Physicochemical and Structural (Q3) Characterization of Topical Drug Products i...

latest-news-card-1
Human Drugs

Tremfya 80% Response Rate in Ulcerative Colitis: Janssen

Janssen Pharmaceutical says new data show that patients given Tremfya (guselkumab) saw a clinical response rate of about 80% in trial subjects with mo...

latest-news-card-1
Human Drugs

FDA Explains Why Zepzelca Will Not be Withdrawn

Responding to a petition seeking the removal of approval for Jazz Pharmaceuticals lung cancer drug Zepzelca, FDA explains why it doesnt agree with the...

Human Drugs

FDA Approves Biologic for Some Myelomas

FDA gives accelerated approval to Janssens teclistamab-cqyv for some adults with relapsed or refractory multiple myeloma.

latest-news-card-1
Human Drugs

FDA Airs Daprodustat Safety Concerns

FDA medical reviewers tell members of the Cardiovascular and Renal Drugs Advisory Committee there are safety concerns with GlaxoSmithKlines anemia dru...

latest-news-card-1
Federal Register

ANDA In Vitro Release Test Studies Guide

Federal Register notice: FDA makes available a draft guidance entitled In Vitro Release Test Studies for Topical Products Submitted in ANDAs.

latest-news-card-1
Human Drugs

CGMP Violations at Nephron SC

FDA warns West Columbia, SC-based Nephron SC about CGMP and other violations at its drug manufacturing facility.

latest-news-card-1
Human Drugs

Panel Reviewing Ipsen NDA Postponed

FDA says it is postponing a 10/31 Endocrinologic and Metabolic Drugs Advisory Committee meeting that was scheduled to review and vote on an Ipsen Biop...